Research and Development

Showing 15 posts of 9607 posts found.

New PV Legislation Implementation Plan by the European Medicines Agency

February 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

Premier Research appoints Sean Russell vice president, Marketing

February 14, 2012 Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell

Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …

Quintiles launches new Asian market service

February 13, 2012 Research and Development Asia, Quintiles, emerging markets

Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …
tim_watts

Oxford BioMedica makes management change

February 10, 2012 Research and Development, Sales and Marketing Oxford BioMedica

Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …

Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team

February 9, 2012 Research and Development

 Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …

European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …
GSK picture

GSK posts strong underlying sales growth

February 8, 2012 Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012 Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

Dietmar Leitner joins Napp Pharmaceuticals as its new managing director

January 31, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals

Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group.   Dietmar has worked …
The Gateway to Local Adoption Series

Latest content